Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
APTX:USNASDAQ GS

Aptinyx Inc

COMPANY INFO
3.22USD
-0.05-1.53%
Market Closed
As of 08/16/2019 EDT
Open
3.31
Prev Close
3.27
Volume
98,582
Market Cap
108.398M
Day Range
3.163.31
52 Week Range
2.8832.25
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/16/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding33.66M
Price to Book Ratio0.8654
Price to Sales Ratio28.2709
1 Year Return-85.88%
30 Day Avg Volume151,131
EPS-1.71
Bloomberg (BEst) EPS Curr Yr-1.9140
Dividend--
Last Dividend Reported--
Earnings Announcement for Period Ending Q3/2019:11/12/2019

Compare
1-Day Performance

-2%0+2%
-2%0+2%
Equity
APTX:US
-1.53%
Sponsored By

About Aptinyx Inc

Aptinyx Inc. operates as a bio-pharmaceutical company. The Company focuses on discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx serves patients in the United States.
Address
909 Davis Street Suite 600 Evanston, IL 60201 United States
Phone
1-847-871-0377
Website
www.aptinyx.com

Income Statement

Quarterly
Annual
;
Q2 2019 (Millions USD)
  • Revenue
    925,000.00
  • Net Income
    -12,131,000.00
  • Profit Margin
    -1,311.46%

Balance Sheet

Quarterly
Annual
Q2 2019 (Millions USD)
  • Total Assets
    130.17
  • Total Liabilities
    5.13
  • Debt to Assets
    0.00%

Cash Flow

Quarterly
Annual
Q2 2019 (Millions USD)
  • Operating
    -11,787,000.00
  • Investing
    -43,000.00
  • Financing
    141,000.00